Hinge Health, Inc. Payments to Acquire Marketable Securities
Hinge Health, Inc. (HNGE) reported Payments to Acquire Marketable Securities of $89.88 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2026-08-06
- Hinge Health, Inc. payments to acquire marketable securities for the quarter ending 2026-06-30 was $30.92M, a 63.67% decline year-over-year.
- Hinge Health, Inc. payments to acquire marketable securities for the quarter ending 2026-03-31 was $58.96M, a 34.62% decline year-over-year.
- Hinge Health, Inc. payments to acquire marketable securities for the quarter ending 2025-12-31 was $154.11M, a 85.05% increase year-over-year.
- Hinge Health, Inc. payments to acquire marketable securities for the quarter ending 2025-09-30 was $142.90M, a 77.52% increase year-over-year.
- Hinge Health, Inc. payments to acquire marketable securities for fiscal 2025 was $472.29M, a 45.52% increase from fiscal 2024.
- Hinge Health, Inc. payments to acquire marketable securities for fiscal 2024 was $324.54M, a 28.41% decline from fiscal 2023.
- Hinge Health, Inc. payments to acquire marketable securities for fiscal 2023 was $453.33M.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $30.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $89.88M 10-Q · filed 2026-08-06 | $243.99M derived: sum of 3 quarters · filed 2026-08-06 | $386.88M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $58.96M 10-Q · filed 2026-05-07 | $213.06M derived: sum of 2 quarters · filed 2026-05-07 | $355.96M derived: sum of 3 quarters · filed 2026-05-07 | $441.07M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $154.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $297.01M derived: sum of 2 quarters · filed 2026-03-03 | $382.12M derived: sum of 3 quarters · filed 2026-08-06 | $472.29M 10-K · filed 2026-03-03 |
| 2025-09-30 | $142.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $228.01M derived: sum of 2 quarters · filed 2026-08-06 | $318.18M 10-Q · filed 2025-11-07 | $401.46M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $85.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $175.28M 10-Q · filed 2026-08-06 | $258.56M derived: sum of 3 quarters · filed 2026-08-06 | $339.06M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $90.17M 10-Q · filed 2026-05-07 | $173.45M derived: sum of 2 quarters · filed 2026-05-07 | $253.95M derived: sum of 3 quarters · filed 2026-05-07 | |
| 2024-12-31 | $83.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $163.78M derived: sum of 2 quarters · filed 2026-03-03 | $324.54M 10-K · filed 2026-03-03 | |
| 2024-09-30 | $80.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $241.26M 10-Q · filed 2025-11-07 | ||
| 2024-06-30 | $160.77M 10-Q · filed 2025-08-11 | |||
| 2023-12-31 | $453.33M 10-K · filed 2026-03-03 |